Yan Li
Fortuna: 25 475 $ al 31/05/2026
Fortuna: 25 475 $ al 31/05/2026
Yan Li is currently the Director at Biocytogen Pharmaceuticals (Beijing) Co., Ltd. starting in 2025.
Ms. Li is also a Member of the Supervisory Board at Eucure Beijing Biopharma Co Ltd since 2020 and a Member of the Supervisory Board at Biocytogen Jiangsu Co., Ltd. since 2023.
Ms. Li completed an undergraduate degree at Renmin University of China in 2014.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/01/2026 | 4.040 ( 0 % ) | 25 475 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Director/Miembro de la Junta | 10/12/2025 |
Eucure Beijing Biopharma Co Ltd | Director/Miembro de la Junta | 01/09/2020 |
Biocytogen Jiangsu Co Ltd | Director/Miembro de la Junta | 01/05/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Renmin University of China
Renmin University of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Commercial Services |
Eucure Beijing Biopharma Co Ltd | |
Biocytogen Jiangsu Co Ltd |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.